Items where authors include "Vital, E"

Export as [feed] Atom [feed] RSS
Number of items: 19.

Article

Rodríguez-Carrio, J, Burska, A, Conaghan, PG orcid.org/0000-0002-3478-5665 et al. (14 more authors) (2023) Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD Open, 9 (1). e002864. ISSN 2056-5933

Watad, A, De Marco, G orcid.org/0000-0003-2406-161X, Mahajna, H et al. (23 more authors) (2021) Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination. Vaccines, 9 (5). ISSN 2076-393X

Psarras, A, Alase, A, Antanaviciute, A et al. (6 more authors) (2020) Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity. Nature Communications, 11. 6149. ISSN 2041-1723

Berekmeri, A, Tiganescu, A orcid.org/0000-0003-3688-2204, Alase, AA et al. (3 more authors) (2019) Non-invasive Approaches for the Diagnosis of Autoimmune/Autoinflammatory Skin Diseases—A Focus on Psoriasis and Lupus erythematosus. Frontiers in Immunology, 10. 1931. ISSN 1664-3224

El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Psarras, A, Md Yusof, M et al. (8 more authors) (2018) A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Scientific Reports, 8. 5793. ISSN 2045-2322

Freeston, J orcid.org/0000-0003-0358-338X and Vital, E orcid.org/0000-0003-1637-4755 (2018) Ultrasound in rheumatology. Medicine, 46 (3). pp. 175-180. ISSN 1357-3039

Pentony, P, Duquenne, L, Dutton, K et al. (4 more authors) (2017) The Initiation of Autoimmunity at Epithelial Surfaces: a Focus on Rheumatoid Arthritis and Systemic Lupus Erythematosus. Discovery Medicine, 24 (133). pp. 191-200. ISSN 1539-6509

Daniel, A, Bagnato, G, Vital, E orcid.org/0000-0003-1637-4755 et al. (1 more author) (2017) Chylous ascites in a patient with an overlap syndrome: a surprising response to rituximab. BMJ Case Reports. bcr-2017-222339. ISSN 1757-790X

Williams, AE, Cherry, L, Blake, A et al. (5 more authors) (2016) An Investigation into the Scale and Impact of Self-Reported Foot Problems Associated with Systemic Lupus Erythematosus: A Study Protocol and Survey Questionnaire Development. Musculoskeletal Care, 14 (2). pp. 110-115. ISSN 1478-2189

Burska, AN, Hunt, L, Boissinot, M et al. (7 more authors) (2014) Autoantibodies to posttranslational modifications in rheumatoid arthritis. Mediators of Inflammation, 2014. 492873. ISSN 0962-9351

Aringer, M and Vital, E (2013) Lots of autoantibodies equal lupus? Arthritis Research and Therapy, 15 (1). 102. ISSN 1478-6354

Book Section

Alcacer-Pitarch, B orcid.org/0000-0002-2208-444X, Vital, E and Buch, M (2019) Autoimmune connective tissue diseases. In: Helliwell, PS, Backhouse, MR and Siddle, HJ, (eds.) The Foot and Ankle in Rheumatology. Oxford University Press . ISBN 9780198734451

Conference or Workshop Item

Md. Yusof, MY, Arnold, J, Saleem, B et al. (5 more authors) (2022) OP0250 BREAKTHROUGH INFECTIONS AND PREDICTING SEVERE COVID OUTCOMES DURING RITUXIMAB THERAPY IN AUTOIMMUNE RHEUMATIC DISEASES. In: EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark.

Arnold, J, Vital, E, Dass, S et al. (5 more authors) (2021) A Personalised Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in Anca-Associated Vasculitis. In: EULAR 2021, 02-05 Jun 2021, Virtual.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Robinson, J, El-Sherbiny, Y et al. (4 more authors) (2019) SAT0009 THE EFFECT OF FCGR3A POLYMORPHISM ON THE INITIAL DEPTH OF B-CELL DEPLETION BY RITUXIMAB, FUNCTIONAL NK-CELL MEDIATED KILLING AND CLINICAL RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS. In: Annual European Congress of Rheumatology, EULAR 2019, 12-15 Jun 2019, Madrid, Spain.

Dutton, K, Psarras, A, El-Sherbiny, Y orcid.org/0000-0003-4791-3475 et al. (3 more authors) (2018) OP0124 In sle patients in sustained low disease activity, novel interferon assays predict flares and glucocorticoid requirements. In: Annual European Congress of Rheumatology, EULAR 2018, 13-16 Jun 2018, Amsterdam, Netherlands.

Yusof, MYM, Vital, E, Dass, S et al. (5 more authors) (2013) Safety of rituximab for remission maintenance in relapsing anca–associated vasculitis: repeat cycles on clinical relapse are associated with low rates of hypogammaglobulinaemia. In: Annual European Congress of Rheumatology EULAR, 12-15 Jun 2013, Spain.

Proceedings Paper

El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Md Yusof, MY orcid.org/0000-0003-3131-9121, Hensor, E orcid.org/0000-0002-5245-4755 et al. (3 more authors) (2016) Surface Tetherin Is A Novel Cell-Specific Biomarker for Interferon Response in Systemic Lupus Erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 546.

Mohamed, AAA, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (6 more authors) (2016) Type I Interferon Activity Is Associated with Mucocutaneous but Not Musculoskeletal Disease Activity in Systemic Lupus Erythematosus:. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 547.

This list was generated on Sun Apr 14 23:30:14 2024 BST.